Follow-up after treatment is an important part of cancer care. Follow-up for acute lymphocytic leukemia (ALL) is often shared among the cancer specialists (oncologists or hematologists) and your family doctor. Your healthcare team will work with you to decide on follow-up care to meet your needs.
Don’t wait until your next scheduled appointment to report any new symptoms and symptoms that don’t go away. Tell your healthcare team if you have:
The chance of ALL recurring is greatest within 5 years after finishing treatment, so close follow-up is needed during this time. If a relapse occurs, it is usually during treatment or shortly after treatment is completed. It is unusual for ALL to return if there are no signs of the disease 5 years after treatment.
Follow-up after ALL is based on your personal needs. It generally lasts for many years. Follow-up visits for ALL are usually scheduled:
During a follow-up visit, your healthcare team will usually ask questions about the side effects of treatment and how you’re coping.
Your doctor may do a physical exam, which can include:
Tests are often part of follow-up care. You may have:
If a recurrence is found, your healthcare team will assess you to determine the best treatment options.
Find out more about these tests and procedures.
To make the decisions that are right for you, ask your healthcare team questions about follow-up.
The Canadian Cancer Society is actively lobbying the federal government to establish a national caregivers strategy to ensure there is more financial support for this important group of people.